These data are consistent with a pivotal role for the JAK/STAT signalling pathway in mediating changes in gene expression that inhibit molecular mechanisms of host immune dysregulation and itch and pain response in patients with AD. The gene discussed is SOAT1; the disease is Alzheimer disease.